interesting study but several glaring issues...case control observational, so limited, weak confounded design, residual confounding risk, no matching, no control for co-morbidites, none for early treatment, none for natural immunity, use of PCR that was false positive, hospital treatment effects...so many issues many explain the estimate…
interesting study but several glaring issues...case control observational, so limited, weak confounded design, residual confounding risk, no matching, no control for co-morbidites, none for early treatment, none for natural immunity, use of PCR that was false positive, hospital treatment effects...so many issues many explain the estimates of effect. but interesting indeed. the patient important outcomes was one strength
Yes, quite right. There are a few other studies with supportive results essentially converging on the same conclusion. However, they too need to be carefully examined. I would not be surprised if sartans do have some protective effect, as there is also a theoretical basis for expecting that they may, and would also not be surprised if the protective effect, if there is one, is then misattributed to the shots.
interesting study but several glaring issues...case control observational, so limited, weak confounded design, residual confounding risk, no matching, no control for co-morbidites, none for early treatment, none for natural immunity, use of PCR that was false positive, hospital treatment effects...so many issues many explain the estimates of effect. but interesting indeed. the patient important outcomes was one strength
Yes, quite right. There are a few other studies with supportive results essentially converging on the same conclusion. However, they too need to be carefully examined. I would not be surprised if sartans do have some protective effect, as there is also a theoretical basis for expecting that they may, and would also not be surprised if the protective effect, if there is one, is then misattributed to the shots.